Shop

Gliclazide (GLIZ) MR 60/1000mg Tablets (30’s) Gliclazide MR 60/1000mg is a modified-release tablet combining Gliclazide 60mg and Metformin Hydrochloride 1000mg. It is designed for effective management of type 2 diabetes mellitus through complementary mechanisms to maintain blood glucose control. Key Features: Gliclazide (60mg, modified release): A sulfonylurea that stimulates pancreatic insulin secretion, with controlled release…

Gliclazide (GLIZ) MR 60mg Tablets (30’s) Gliclazide MR 60mg is a modified-release oral antidiabetic medication belonging to the sulfonylurea class. It is prescribed for managing blood glucose levels in patients with type 2 diabetes mellitus. Key Features: Stimulates pancreatic beta cells to release insulin, helping reduce blood sugar. Modified-release formulation ensures a steady release, providing…

Glifempa-Lin Tablets (30’s) Glifempa-Lin is a combination oral antidiabetic medication containing Empagliflozin (SGLT2 inhibitor) and Linagliptin (DPP-4 inhibitor). It is used to improve glycemic control in adults with type 2 diabetes mellitus. Key Features: Dual-action formula: Empagliflozin reduces glucose reabsorption in the kidneys, while Linagliptin increases insulin secretion and decreases glucagon levels. Once-daily oral dosing…

Glifempa-Lin-XR Tablets (30’s) Glifempa-Lin-XR is an extended-release oral antidiabetic combination containing Empagliflozin, Linagliptin, and Metformin XR. It is designed for adults with type 2 diabetes mellitus who require multiple mechanisms of action for optimal glycemic control. Key Features: Triple-action formula: Empagliflozin (SGLT2 inhibitor): Promotes glucose excretion via urine. Linagliptin (DPP-4 inhibitor): Enhances insulin secretion and…